SMTI Sanara MedTech Inc

Price (delayed)

$31.3

Market cap

$269.97M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.59

Enterprise value

$278.84M

With a focus on improving patient outcomes through evidence-based healing solutions and services, Sanara MedTech Inc. markets and distributes wound and skin care products and is seeking to offer wound ...

Highlights
Sanara MedTech's gross profit has increased by 32% YoY and by 6% QoQ
The company's revenue rose by 27% YoY and by 4.6% QoQ
SMTI's EPS is up by 19% year-on-year but it is down by 13% since the previous quarter
Sanara MedTech's net income has increased by 18% YoY but it has decreased by 14% QoQ
SMTI's quick ratio is down by 27% YoY and by 4% QoQ

Key stats

What are the main financial stats of SMTI
Market
Shares outstanding
8.63M
Market cap
$269.97M
Enterprise value
$278.84M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.23
Price to sales (P/S)
3.88
EV/EBIT
N/A
EV/EBITDA
1,255.21
EV/Sales
4.1
Earnings
Revenue
$68M
EBIT
-$4.15M
EBITDA
$222,147
Free cash flow
-$3.4M
Per share
EPS
-$0.59
Free cash flow per share
-$0.4
Book value per share
$5.02
Revenue per share
$8.08
TBVPS
$2.77
Balance sheet
Total assets
$70.91M
Total liabilities
$27.9M
Debt
$11.7M
Equity
$43.29M
Working capital
$4.44M
Liquidity
Debt to equity
0.27
Current ratio
1.35
Quick ratio
0.95
Net debt/EBITDA
39.94
Margins
EBITDA margin
0.3%
Gross margin
88.8%
Net margin
-7.2%
Operating margin
-11.2%
Efficiency
Return on assets
-7%
Return on equity
-11.3%
Return on invested capital
-24.9%
Return on capital employed
-7.1%
Return on sales
-6.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SMTI stock price

How has the Sanara MedTech stock price performed over time
Intraday
3.81%
1 week
5.53%
1 month
11.91%
1 year
-25.21%
YTD
-23.84%
QTD
10.91%

Financial performance

How have Sanara MedTech's revenue and profit performed over time
Revenue
$68M
Gross profit
$60.39M
Operating income
-$7.59M
Net income
-$4.89M
Gross margin
88.8%
Net margin
-7.2%
The company's operating margin rose by 46% YoY and by 5% QoQ
Sanara MedTech's net margin has increased by 36% YoY but it has decreased by 9% QoQ
Sanara MedTech's gross profit has increased by 32% YoY and by 6% QoQ
The operating income is up by 32% YoY

Growth

What is Sanara MedTech's growth rate over time

Valuation

What is Sanara MedTech stock price valuation
P/E
N/A
P/B
6.23
P/S
3.88
EV/EBIT
N/A
EV/EBITDA
1,255.21
EV/Sales
4.1
SMTI's EPS is up by 19% year-on-year but it is down by 13% since the previous quarter
The price to book (P/B) is 47% lower than the 5-year quarterly average of 11.7 and 15% lower than the last 4 quarters average of 7.3
SMTI's equity is up by 4% year-on-year but it is down by 3.4% since the previous quarter
The P/S is 50% lower than the 5-year quarterly average of 7.8 and 21% lower than the last 4 quarters average of 4.9
The company's revenue rose by 27% YoY and by 4.6% QoQ

Efficiency

How efficient is Sanara MedTech business performance
Sanara MedTech's return on invested capital has surged by 86% YoY and by 7% QoQ
SMTI's return on sales has surged by 72% year-on-year but it is down by 3.4% since the previous quarter
The company's return on assets rose by 33% YoY but it fell by 9% QoQ
The company's return on equity rose by 22% YoY but it fell by 13% QoQ

Dividends

What is SMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SMTI.

Financial health

How did Sanara MedTech financials performed over time
The company's total assets is 154% higher than its total liabilities
The company's total liabilities has surged by 51% YoY but it fell by 4.7% QoQ
SMTI's quick ratio is down by 27% YoY and by 4% QoQ
Sanara MedTech's debt is 73% lower than its equity
SMTI's debt to equity is up by 3.8% since the previous quarter
SMTI's equity is up by 4% year-on-year but it is down by 3.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.